StemImmune LLC

08/17/2026

Rethinking CAR-T: Changing the Battlefield, Not Just the Cells

We may be spending too much effort asking how to make CAR-T cells kill harder and survive longer.

A more important question may be: why is the tumor able to survive in that tissue at all?

If engineered immune cells can reshape macrophages, stromal support, cytokine signaling and endogenous immunity, then the goal changes. CAR-T no longer has to be the permanent army. It can become the intervention that changes the battlefield itself.

That may be where the next real advance begins.
Read more: https://stem-immune.com/car-t-next-revolution-tumor-ecosystem-reprogramming

08/10/2026

Can Vitamin C Rewrite Cellular Memory? From iPSC Reprogramming to Hematopoietic Aging

🧬Can Vitamin C Rewrite Cellular Memory?

Vitamin C is usually associated with nutrition and antioxidant defense. But over the past 16 years, stem cell research has revealed a much more intriguing story.

In 2010, researchers showed that vitamin C could enhance iPSC reprogramming. Later studies connected vitamin C to TET-dependent epigenetic regulation and hematopoietic stem cell homeostasis.

Now, a 2026 Cell Stem Cell study reports that long-term vitamin C intervention can attenuate several molecular and progenitor-level features of aging in primate bone marrow.

The bigger question may not be whether vitamin C is simply “anti-aging.”

Can metabolism influence cellular memory—and how much plasticity does an aging stem cell system still retain?

Our new StemImmune article follows this fascinating scientific journey from iPSC reprogramming to hematopoietic aging.

Read the full article at StemImmune: https://stem-immune.com/vitamin-c-stem-cell-plasticity-reprogramming-hematopoietic-aging

08/10/2026

🧬Can Vitamin C Rewrite Cellular Memory?

Vitamin C is usually associated with nutrition and antioxidant defense. But over the past 16 years, stem cell research has revealed a much more intriguing story.

In 2010, researchers showed that vitamin C could enhance iPSC reprogramming. Later studies connected vitamin C to TET-dependent epigenetic regulation and hematopoietic stem cell homeostasis.

Now, a 2026 Cell Stem Cell study reports that long-term vitamin C intervention can attenuate several molecular and progenitor-level features of aging in primate bone marrow.

The bigger question may not be whether vitamin C is simply “anti-aging.”

Can metabolism influence cellular memory—and how much plasticity does an aging stem cell system still retain?

Our new StemImmune article follows this fascinating scientific journey from iPSC reprogramming to hematopoietic aging.

Read the full article at StemImmune: https://stem-immune.com/vitamin-c-stem-cell-plasticity-reprogramming-hematopoietic-aging

08/07/2026

VEGF‑165 is more than a classic angiogenic factor—it is a context-dependent developmental signal connecting vascular specification, hemogenic endothelium, early hematopoiesis and organoid vascularization.

Our latest StemImmune Perspective explores how VEGF‑165 works together with BMP‑4, Activin/Nodal, FGF, WNT and Notch during stem cell differentiation.

Read the full article:
https://stem-immune.com/vegf-165-stem-cell-differentiation-hemogenic-endothelium-organoids

For research use only.

08/04/2026

We are pleased to share StemImmune Perspectives, Volume 2:

From CAR Engineering to Cell-Fate Programming
Toward a Programmable Operating System for Next-Generation iPSC-Derived Immune-Cell Therapy

CAR technology taught us how to engineer immune recognition. The next challenge is to program the entire therapeutic cell life cycle—from developmental identity and lineage selection to contextual decision-making, persistence, safety and termination.

This Perspective explores iPSC-derived CAR-T, CAR-NK, CAR-NKT and myeloid therapies, together with gene circuits, epigenetic control, adaptive feedback and lifecycle quality assessment.

The future of cell therapy may not simply be stronger cells, but cells whose destiny can be precisely programmed.

Read the Perspective:
https://stem-immune.com/from-car-engineering-to-cellular-destiny-programming

DOI:
https://doi.org/10.5281/zenodo.21798307

07/29/2026

🧬 Introducing StemImmune Perspectives – Volume 1

I'm excited to share the first volume of StemImmune Perspectives, an independent platform for scientific perspectives and scholarly discussion in regenerative medicine.

Our inaugural Perspective, "ISSCR 2026: Six Scientific Signals Shaping the Next Era of Regenerative Medicine," examines the recurring themes emerging from ISSCR 2026 and explores how developmental biology, organoids, artificial intelligence, cell manufacturing, and clinical translation are converging to reshape the future of regenerative medicine.

Rather than simply summarizing conference presentations, this Perspective asks a broader question:

What scientific signals will define the next decade of regenerative medicine?

I hope this article encourages thoughtful discussion and provides useful insights for researchers, clinicians, and biotechnology professionals interested in where the field is heading.

📖 Read the full Perspective:
https://stem-immune.com/isscr-2026-six-scientific-signals-regenerative-medicine

I welcome your comments, questions, and perspectives.

07/17/2026

🧠 StemImmune Scientific Perspective

From Prediction to Prevention: How Blood Biomarkers Could Change the Way We Think About Alzheimer's Disease

Could a blood test identify Alzheimer's disease risk before memory loss begins?

A new study published in JAMA suggests that plasma p-tau217 may help estimate future cognitive decline years before symptoms appear.

Our latest scientific perspective explores:

✔ Why p-tau217 has become one of the most promising Alzheimer's biomarkers

✔ What the latest clinical evidence tells us

✔ Current limitations of blood-based testing

✔ How early risk identification may influence prevention strategies and clinical trial design

✔ The future of precision neurology

As medicine moves toward earlier diagnosis and personalized intervention, blood biomarkers may become an important part of the next generation of Alzheimer's research.

📖 Read the full article:

https://stem-immune.com/index.php?route=extension/d_blog_module/post&post_id=67

StemImmune Scientific Perspective

Advancing Stem Cell, Immunology & Precision Medicine Research

We welcome your thoughts and discussion.

04/13/2026

Could humans one day regrow a lost limb?

A fascinating new study published in Science suggests the answer may not be “impossible.”

Researchers found that mammals may still carry the hidden genetic program needed for limb regeneration—but it is switched off because our cells are too sensitive to oxygen.

When mouse limb tissue was placed in a lower-oxygen environment, it began to act more like a regenerating salamander limb:

✓ Faster wound closure
✓ Activation of the HIF1A pathway
✓ Regenerative genes turned back on
✓ Less scarring and abnormal cartilage formation

Even more exciting, when low oxygen was combined with specific growth factors, the tissue began expressing key genes required for limb regeneration.

The implication is remarkable: humans may not have lost the ability to regenerate—we may simply have locked it away.

While true human limb regrowth is still far in the future, this study opens a new path for regenerative medicine, tissue engineering, and advanced wound healing.

Read more on StemImmune’s latest blog: stem-immune.com/blog